Please login to the form below

Not currently logged in
Email:
Password:

FlowMetric Diagnostics names president

Amy Williams has over 25 years of experience in life sciences

FlowMetric Diagnostics, a provider of flow cytometry and cell sorting services, has appointed Amy Williams as its president.

Williams has over 25 years of experience in the life science industry. Prior to joining FlowMetric Diagnostics, Williams was president of SageWorks Rx, a consulting company to the life science industry.

Commenting on her appointment, she said: “I am pleased and excited to be given this opportunity to lead FlowMetric Diagnostics.

“It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and patients.”

Williams has held a variety of commercial leadership roles at Merck and Endo Pharmaceuticals and also has expertise in marketing, sales and reimbursement. She has additionally helped launch new products and indications, creating and implementing contract reimbursement strategies.

Ren Capocasale, chairman of the board, FlowMetric Diagnostics and CEO and founder of parent company Flowmetric Inc, added: “Amy brings a wealth of experience to support our business and commercialisation initiatives and will play a pivotal role in leading and executing our business strategy now and in the years ahead.”

Williams will also join the company's board of directors.

17th December 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics